Literature DB >> 27104796

Home blood pressure monitor use in patients with chronic kidney disease.

Xiaojing Ye1, Salman Shafi2, Andrea Negrete3, William N Davis3, Erdal Sarac1,4, Alejandro M Negrete5, Hilmer Negrete1.   

Abstract

Home blood pressure monitoring (HBPM) is recommended in patients with chronic kidney disease (CKD) and hypertension (HTN). However, little is known about the use and pattern of HBPM in CKD patients. A cross-sectional study was conducted in an out-patient nephrology clinic. A total of 285 patients participated in the study. Of all patients, 66% reported using HBPM. Self-reported compliance with BP medications (93.9% vs. 85.1%, p 0.03), exercise >3 days/week (45.9 vs. 26.3%, p <0.001) and dietary sodium restriction (85.6% vs. 71.6%, p < 0.001) were more common in HBPM users vs. non-HBPM users. Most patients with HBPM used upper arm cuff (82.3%), reported receiving education on correct use of HBPM (82.5%), had perception that home BP was controlled (75.4%) and believed that HBPM is helpful in managing hypertension (85.4%). Most common reason for not using HBPM was lack of advice by a physician (43.4%). HBPM use is common in patients with CKD and HTN. HBPM users are more likely to follow life-style and dietary modifications for blood pressure control.

Entities:  

Keywords:  Chronic kidney disease; home blood pressure monitoring; hypertension

Mesh:

Year:  2016        PMID: 27104796     DOI: 10.3109/08037051.2016.1167356

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  2 in total

1.  Factors Associated With Physician Recommendation of Home Blood Pressure Monitoring and Blood Pressure in the US Population.

Authors:  Olive Tang; Kathryn Foti; Edgar R Miller; Lawrence J Appel; Stephen P Juraschek
Journal:  Am J Hypertens       Date:  2020-09-10       Impact factor: 2.689

2.  Assessing the routine-practice gap for home blood pressure monitoring among Chinese adults with hypertension.

Authors:  Hui-Juan Zuo; Ji-Xiang Ma; Jin-Wen Wang; Xiao-Rong Chen
Journal:  BMC Public Health       Date:  2020-11-23       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.